dc.contributor.author |
Lodochnikova O. |
|
dc.contributor.author |
Kosolapova L. |
|
dc.contributor.author |
Saifina A. |
|
dc.contributor.author |
Gubaidullin A. |
|
dc.contributor.author |
Fayzullin R. |
|
dc.contributor.author |
Khamatgalimov A. |
|
dc.contributor.author |
Litvinov I. |
|
dc.contributor.author |
Kurbangalieva A. |
|
dc.date.accessioned |
2018-04-05T07:10:18Z |
|
dc.date.available |
2018-04-05T07:10:18Z |
|
dc.date.issued |
2017 |
|
dc.identifier.uri |
http://dspace.kpfu.ru/xmlui/handle/net/130354 |
|
dc.description.abstract |
The purposeful change of crystallization conditions for rac-3-chloro-5-hydroxy-1-(4-methylbenzyl)-4-[(4-methylphenyl)sulfanyl]-1,5-dihydro-2H-pyrrol-2-one 1 leads to two different crystal modifications, namely, a racemic compound in the triclinic space group P1 with Z′ = 1 (α-1) and a partial solid solution based on a racemic compound in the monoclinic space group P2 1 with Z′ = 4 (β-1). The first modification, α-1, is characterized by a higher density of the molecular packing in the crystal, while the second one, β-1, by a stronger system of hydrogen bonds and the presence of positional and substitutional disorder simultaneously. The analysis of the crystal structure of modifications α and β allowed us to define some structural aspects of the partial solid solution formation. Namely, the tendency to build a stronger hydrogen bond system enables the solution of enantiomers of 1 to be formed in the crystalline phase, whereas the propensity of the molecules to adopt a more favorable transoid conformation limits the solubility of the minor enantiomer. 2017 The Royal Society of Chemistry. |
|
dc.title |
Structural aspects of partial solid solution formation: Two crystalline modifications of a chiral derivative of 1,5-dihydro-2: H -pyrrol-2-one under consideration |
|
dc.type |
Article |
|
dc.relation.ispartofseries-issue |
48 |
|
dc.relation.ispartofseries-volume |
19 |
|
dc.collection |
Публикации сотрудников КФУ |
|
dc.relation.startpage |
7277 |
|
dc.source.id |
SCOPUS-2017-19-48-SID85038232798 |
|